BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 35356927)

  • 1. Can adjuvant chemotherapy improve the prognosis of adult ovarian granulosa cell tumors?: A narrative review.
    Zhuang Y; Zhang S; Liu Y; Yang H
    Medicine (Baltimore); 2022 Mar; 101(11):. PubMed ID: 35356927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of different treatment modalities for the management of adult-onset granulosa cell tumours of the ovary (primary and recurrent).
    Gurumurthy M; Bryant A; Shanbhag S
    Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD006912. PubMed ID: 24753008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer.
    Lawrie TA; Winter-Roach BA; Heus P; Kitchener HC
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD004706. PubMed ID: 26676202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer.
    Winter-Roach BA; Kitchener HC; Lawrie TA
    Cochrane Database Syst Rev; 2012 Mar; 3(3):CD004706. PubMed ID: 22419298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy of advanced ovarian juvenile granulosa cell tumors.
    Schneider DT; Calaminus G; Wessalowski R; Pathmanathan R; Harms D; Göbel U
    Klin Padiatr; 2002; 214(4):173-8. PubMed ID: 12165898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics and outcome of recurrence in molecularly defined adult-type ovarian granulosa cell tumors.
    Bryk S; Färkkilä A; Bützow R; Leminen A; Tapper J; Heikinheimo M; Unkila-Kallio L; Riska A
    Gynecol Oncol; 2016 Dec; 143(3):571-577. PubMed ID: 27729108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer.
    Winter-Roach BA; Kitchener HC; Dickinson HO
    Cochrane Database Syst Rev; 2009 Jul; (3):CD004706. PubMed ID: 19588360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical cytoreduction for recurrent epithelial ovarian cancer.
    Al Rawahi T; Lopes AD; Bristow RE; Bryant A; Elattar A; Chattopadhyay S; Galaal K
    Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD008765. PubMed ID: 23450588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of systemic chemotherapy in the management of granulosa cell tumors.
    Meisel JL; Hyman DM; Jotwani A; Zhou Q; Abu-Rustum NR; Iasonos A; Pike MC; Aghajanian C
    Gynecol Oncol; 2015 Mar; 136(3):505-11. PubMed ID: 25546114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Prognostic Significance of Adjuvant Chemotherapy in Adult Ovarian Granulosa Cell Tumors: A Systematic Review and Meta-analysis.
    Zhuang Y; Yang H
    Cancer Control; 2023; 30():10732748231215165. PubMed ID: 37957122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic profiling of primary and recurrent adult granulosa cell tumors of the ovary.
    Da Cruz Paula A; da Silva EM; Segura SE; Pareja F; Bi R; Selenica P; Kim SH; Ferrando L; Vahdatinia M; Soslow RA; Vidal A; Gatius S; Przybycin CG; Abu-Rustum NR; Matias-Guiu X; Rubin BP; Reis-Filho JS; DeLair DF; Weigelt B
    Mod Pathol; 2020 Aug; 33(8):1606-1617. PubMed ID: 32203090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic drug sensitivity testing reveals synergistic growth inhibition by dasatinib or mTOR inhibitors with paclitaxel in ovarian granulosa cell tumor cells.
    Haltia UM; Andersson N; Yadav B; Färkkilä A; Kulesskiy E; Kankainen M; Tang J; Bützow R; Riska A; Leminen A; Heikinheimo M; Kallioniemi O; Unkila-Kallio L; Wennerberg K; Aittokallio T; Anttonen M
    Gynecol Oncol; 2017 Mar; 144(3):621-630. PubMed ID: 28104295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is adjuvant chemotherapy necessary for 2014 FIGO stage IC adult granulosa cell tumor?: Multicentric Turkish study.
    Erdogan O; Kilic C; Cakir C; Kilic F; Oktar O; Ersak B; Sahin M; Tokalioglu A; Kocak O; Ozturk C; Gorgulu G; Gokkaya M; Selcuk I; Korkmaz V; Comert GK; Toptas T; Ureyen I; Ucar G; Taskin S; Tasci T; Uncu D; Narin MA; Boran N; Ozdal B; Tekin OM; Ustun Y; Sancı M; Ortac F; Turan T
    Asia Pac J Clin Oncol; 2024 Feb; 20(1):46-54. PubMed ID: 37096294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer.
    Winter-Roach BA; Kitchener HC; Dickinson HO
    Cochrane Database Syst Rev; 2009 Jan; (1):CD004706. PubMed ID: 19160239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal primary surgical treatment for advanced epithelial ovarian cancer.
    Elattar A; Bryant A; Winter-Roach BA; Hatem M; Naik R
    Cochrane Database Syst Rev; 2011 Aug; 2011(8):CD007565. PubMed ID: 21833960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy for malignant germ cell ovarian cancer in adult patients with early stage, advanced and recurrent disease.
    Abdul Razak AR; Li L; Bryant A; Diaz-Padilla I
    Cochrane Database Syst Rev; 2011 Mar; 2011(3):CD007584. PubMed ID: 21412906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulosa Cell Tumor of the Ovary: A Retrospective Study of 31 Cases and a Review of the Literature.
    Dridi M; Chraiet N; Batti R; Ayadi M; Mokrani A; Meddeb K; Yahiaoui Y; Raies H; Mezlini A
    Int J Surg Oncol; 2018; 2018():4547892. PubMed ID: 29796312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic overview of chemotherapy effects in ovarian cancer.
    Högberg T; Glimelius B; Nygren P;
    Acta Oncol; 2001; 40(2-3):340-60. PubMed ID: 11441940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant chemotherapy does not improve disease-free survival in FIGO stage IC ovarian granulosa cell tumors: The MITO-9 study.
    Mangili G; Ottolina J; Cormio G; Loizzi V; De Iaco P; Pellegrini DA; Candiani M; Giorda G; Scarfone G; Cecere SC; Frigerio L; Gadducci A; Marchetti C; Ferrandina G
    Gynecol Oncol; 2016 Nov; 143(2):276-280. PubMed ID: 27597380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.